Implanted spinal neuromodulation interventions for chronic pain in adults

CONCLUSIONS: We found very low-certainty evidence that SCS may not provide clinically important benefits on pain intensity compared to placebo stimulation. We found low- to very low-certainty evidence that SNMD interventions may provide clinically important benefits for pain intensity when added to conventional medical management or physical therapy. SCS is associated with complications including infection, electrode lead failure/migration and a need for reoperation/re-implantation. The level of certainty regarding the size of those risks is very low. SNMD may lead to serious adverse events, including death. We found no evidence to support or refute the use of DRGS for chronic pain.PMID:34854473 | PMC:PMC8638262 | DOI:10.1002/14651858.CD013756.pub2
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Source Type: research